Conservative Beaver

News stories of interest to Proud Canadians

Ad

Ad

America

Phase 2 trials of antiviral pill show promising results in battling COVID-19

RN Todd Paul enters the apartment building and passes a sign calling for Covid-19 safety as he makes his way to visit his veteran/patient's home in Boston, Massachusetts on March 4, 2021. - The mobile vaccination team is in it's fifth week of at home vaccinations and has vaccinated 183 veterans so far. Today marks the first day the Johnson & Johnson single shot Covid-19 Vaccine will be used. Boston VA received 300 vials of the Johnson & Johnson single shot Covid-19 vaccine so far and expects more on the way. (Photo by Joseph Prezioso / AFP) (Photo by JOSEPH PREZIOSO/AFP via Getty Images)

RN Todd Paul enters the apartment building and passes a sign calling for Covid-19 safety as he makes his way to visit his veteran/patient’s home in Boston, Massachusetts on March 4, 2021. Photo by JOSEPH PREZIOSO/AFP via Getty Images)

OAN Newsroom
UPDATED 1:16 PM PT – Wednesday, March 10, 2021

Two American companies teamed up to produce an anti-viral pill used to combat the coronavirus. According to recent reports, the drug molnupiravirperf performed well in early-stage trials.

Ridgeback Biotherapeutics and Merck said their pill is a five day, at-home treatment aimed to reduce the damage done by the virus as well as cut down on the time it takes to receive a negative test after being infected.

RAHWAY, NJ - NOVEMBER 29: A man walks by a sign at a Merck plant November 29, 2005 in Rahway, New Jersey. U.S. pharmaceutical giant Merck, announced plans to cut some 7,000 jobs, or 11 percent of its global workforce, by the end of 2008. (Photo by Marko Georgiev/Getty Images)

A man walks by a sign at a Merck plant in Rahway, New Jersey. (Photo by Marko Georgiev/Getty Images)

Researchers are optimistic about the pill’s capabilities.

“It might be one of those drugs, fingers crossed, that it doesn’t matter what virus you have,” USF Associate Professor of Pediatrics Medicine Michael Teng Ph.D. stated. “If you have these respiratory symptoms, take this drug, it will probably hit that virus.”

Doctors that have studied the medication are calling it a potential “holy grail.” They noted it could be made available in the next four to five months.

MORE NEWS: SFPD Arrest Man Suspected Of Robbing Reporter In Bay Area

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *